Patents by Inventor Harm Hogenesch

Harm Hogenesch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10159750
    Abstract: The invention described herein pertains to compounds and conjugates, to compositions, complexes and formulations comprising the compounds and/or conjugates, and to methods of use of the compounds, conjugates and their compositions, complexes and formulations in vaccines and vaccinations and generating immune responses.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: December 25, 2018
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Richard Frederic Borch, Irene A. George, Harm Hogenesch, Stanley L. Hem
  • Publication number: 20180289820
    Abstract: The invention described herein pertains to compounds and conjugates, to compositions, complexes and formulations comprising the compounds and/or conjugates, and to methods of use of the compounds, conjugates and their compositions, complexes and formulations in vaccines and vaccinations and generating immune responses.
    Type: Application
    Filed: June 8, 2018
    Publication date: October 11, 2018
    Applicant: Purdue Research Foundation
    Inventors: Richard Frederic Borch, Irene A. George, Harm Hogenesch, Stanley L. Hem
  • Patent number: 10010616
    Abstract: The invention described herein pertains to compounds and conjugates, to compositions, complexes and formulations comprising the compounds and/or conjugates, and to methods of use of the compounds, conjugates and their compositions, complexes and formulations in vaccines and vaccinations and generating immune responses.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: July 3, 2018
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Richard Frederic Borch, Irene A. George, Harm Hogenesch, Stanley L. Hem, Lawrence E. Hem
  • Patent number: 9821055
    Abstract: The present invention provides a new adjuvant for administering vaccines.
    Type: Grant
    Filed: November 7, 2015
    Date of Patent: November 21, 2017
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Harm HogenEsch, Yuan Yao
  • Publication number: 20170128567
    Abstract: The present invention provides a new adjuvant for administering vaccines.
    Type: Application
    Filed: November 7, 2015
    Publication date: May 11, 2017
    Applicant: Purdue Research Foundation
    Inventors: Harm HogenEsch, Yuan Yao
  • Publication number: 20020028213
    Abstract: An improved species specific vaccine having reduced risks of engendering autoimmune disease in vaccinated animals is described. The vaccine is formulated to be substantially free of heterologous species serum components. Preferably the species specific vaccines are produced from antigen concentrates recovered from cell culture media comprising serum wherein the serum consists essentially of homologous species serum.
    Type: Application
    Filed: August 20, 2001
    Publication date: March 7, 2002
    Inventors: Lawrence T. Glickman, Harm Hogenesch